Leila Antonangelo Selected Research

Pleurodesis

1/2016	Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
9/2015	A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.
4/2013	Effectiveness and safety of iodopovidone in an experimental pleurodesis model.
10/2012	Monoclonal antibodies anti-TGFβ1 and anti-VEGF inhibit the experimental pleurodesis induced by silver nitrate.
12/2011	Blockage of vascular endothelial growth factor (VEGF) reduces experimental pleurodesis.
8/2009	Low doses of silver nitrate induce pleurodesis with a limited systemic response.
12/2007	Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis.
7/2007	Pleurodesis: a novel experimental model.
12/2006	Experimental pleurodesis induced by antibiotics (macrolides or quinolones).
8/2005	Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leila Antonangelo Research Topics

Disease

12	Inflammation (Inflammations) 07/2018 - 06/2004
9	Pleural Effusion (Pleural Effusions) 01/2019 - 07/2006
7	COVID-19 05/2022 - 01/2021
6	Malignant Pleural Effusion 01/2016 - 08/2005
6	Fibrosis (Cirrhosis) 10/2012 - 03/2006
5	Rheumatic Diseases (Rheumatism) 05/2022 - 10/2021
5	Tuberculosis (Tuberculoses) 11/2012 - 09/2007
4	Neoplasms (Cancer) 01/2016 - 01/2004
3	Pleural Tuberculosis 11/2012 - 07/2006
2	Visceral Leishmaniasis (Kala Azar) 06/2021 - 01/2021
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2021
2	Pneumonia (Pneumonitis) 07/2018 - 04/2009
2	Edema (Dropsy) 01/2018 - 12/2002
2	Lymphoma (Lymphomas) 01/2016 - 03/2012
2	Pain (Aches) 04/2009 - 08/2005
1	Systemic Scleroderma (Systemic Sclerosis) 05/2022
1	Rheumatoid Arthritis 05/2022
1	Vasculitis (Vasculitides) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021
1	Human Influenza (Influenza) 10/2021
1	Leishmaniasis 06/2021
1	Shock 01/2021
1	Nausea 01/2021
1	Pharyngitis (Sore Throat) 01/2021
1	Anemia 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Infections 01/2021
1	Type 2 Diabetes Mellitus (MODY) 04/2019
1	Insulin Resistance 04/2019
1	Obesity 04/2019
1	Experimental Arthritis 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Synovitis 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Arthritis (Polyarthritis) 01/2018

Drug/Important Bio-Agent (IBA)

7	Adenosine DeaminaseIBA 01/2019 - 07/2006
7	Talc FDA Link 11/2009 - 12/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 12/2007
5	Silver NitrateIBA 11/2009 - 08/2005
4	sinovac COVID-19 vaccineIBA 05/2022 - 10/2021
4	CollagenIBA 01/2018 - 03/2006
3	COVID-19 VaccinesIBA 05/2022 - 01/2022
3	Immunoglobulin G (IgG)IBA 05/2022 - 01/2022
3	Cholecalciferol (Vitamin D3)FDA Link 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 04/2019 - 10/2007
3	Interleukin-8 (Interleukin 8)IBA 11/2012 - 06/2004
2	Inactivated VaccinesIBA 05/2022 - 10/2021
2	amsonic acid (DAS)IBA 02/2022 - 03/2012
2	CytokinesIBA 01/2022 - 01/2012
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2021
2	25-hydroxyvitamin DIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 07/2018 - 01/2018
2	BiofuelsIBA 07/2018 - 07/2010
1	BNT162 VaccineIBA 05/2022
1	AntibodiesIBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Leflunomide (Arava)FDA LinkGeneric 05/2022
1	Rituximab (Mabthera)FDA Link 05/2022
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 04/2022
1	Attenuated VaccinesIBA 04/2022
1	Propiolactone FDA Link 02/2022
1	ChemokinesIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	VaccinesIBA 10/2021
1	Lipid NanoparticlesIBA 06/2021
1	Ursolic AcidIBA 06/2021
1	LipidsIBA 06/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Pentacyclic TriterpenesIBA 01/2021
1	L 35 (L35)IBA 01/2021
1	TriterpenesIBA 01/2021
1	hydroxide ionIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	IncretinsIBA 04/2019
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 04/2019
1	GlycogenIBA 04/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 01/2019
1	Endothelins (Endothelin)IBA 07/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2018
1	IsoprostanesIBA 07/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2018
1	Collagen Type V (Type V Collagen)IBA 01/2018
1	Caspase 9IBA 01/2018
1	Freund's AdjuvantIBA 01/2018
1	methylated bovine serum albumin (MBSA)IBA 01/2018

Therapy/Procedure

12	Pleurodesis 01/2016 - 12/2002
3	Length of Stay 01/2021 - 01/2021
2	Therapeutics 01/2018 - 09/2015
2	Drug Therapy (Chemotherapy) 09/2010 - 12/2007
1	Intramuscular Injections 02/2022
1	Caloric Restriction 04/2019
1	Gastrostomy 04/2019
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 04/2019
1	Resistance Training 01/2018
1	Oral Administration 01/2018